XML 65 R21.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

SUBSEQUENT EVENT	12 Months Ended
	Dec. 31, 2019
SUBSEQUENT EVENT
SUBSEQUENT EVENT	(15)  SUBSEQUENT EVENTS See Note 9 – Leases above for a discussion regarding the lease agreement entered into in January 2020. On February 25, 2020 the Company announced the FDA granted 510(k) clearance for sale in the U.S. for the CM-1500 Blood Volume Monitor.

X

- References

No definition available.

+ Details

Name:	us-gaap_SubsequentEventsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 855
-URI http://asc.fasb.org/topic&trid=2122774

+ Details

Name:	us-gaap_SubsequentEventsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration